Member Exclusive INTERVIEW

Developing and commercializing peptide therapeutics for nerve regeneration: an interview with NervGen Pharma

Learn more about NervGen Pharma (BC, USA), a company developing innovative peptide-based therapeutics to treat spinal cord injuries.

Go to the profile of RegMedNet
May 15, 2019

Please sign in or register for FREE

No comments yet.